Main menu

London Calling 2023: Using nanopore sequencing to understand the manufacture, delivery, and action of mRNA vaccines


The lifecycle of an mRNA vaccine begins with its manufacture and formulation into lipid nanoparticles. The mRNA is then delivered to patients, where it is taken up by recipient cells and translated into the encoded protein. This study uses Oxford Nanopore cDNA and direct RNA sequencing to analyze each step in the mRNA vaccine lifecycle. We first show that Oxford Nanopore sequencing can be used during mRNA manufacturing to monitor mRNA quality and integrity, and detect contaminating RNA species that can induce unwanted inflammatory responses. Then, we directly measure the impact of different degradation pathways on mRNA integrity during formulation and storage. Finally, we describe the uptake, expression, and final degradation of mRNA vaccines within cells. Together, this study uses Oxford Nanopore sequencing to trace the lifecycle of an mRNA vaccine, providing quality data throughout the manufacturing process and insight into its mode of action within the cell.

Authors: Helen Gunter

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag